Merit Medical Systems | MMSI - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
3M USD 2.46B 398M 2026-03
Abbott USD 5.86B 675M 2026-03
AngioDynamics USD 44.78M 2.93M 2025-09
Anika Therapeutics USD 19.18M 3.6M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 735.4M 40.2M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
J&J USD 18.55B 1.31B 2026-06
Medtronic USD 6.01B 595M 2026-03
Merit Medical Systems USD 184.8M 10.56M 2026-03
Olympus JPY 192.76B 27.86B 2026-03
Pfizer USD 11.04B 1.24B 2026-03
STAAR Surgical USD 43.74M 34.13M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Terumo JPY 149.02B 4.17B 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12